Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.72p
   
  • Change Today:
    -0.029p
  • 52 Week High: 14.90
  • 52 Week Low: 2.70
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 435,665
  • Market Cap: £13.61m
  • Beta: 0.00

Poolbeg Pharma Overview

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the “one-stop shop” for Big Pharma seeking mid-stage products to license or acquire.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 1.0  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Poolbeg Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (2.34) (0.74)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (4.78) (0.94)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (4.51) (0.79)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Poolbeg Pharma Company Announcements

Form 8.5 (EPT/NON-RI) 25-Feb-2025 08:50 RNS
Form 8.5 (EPT/NON-RI) 24-Feb-2025 08:48 RNS
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc 21-Feb-2025 11:53 GlobeNewswire NA

Poolbeg Pharma ShareCast News

Poolbeg shares slide as Hookipa terminates takeo... 21-Feb-2025 ShareCast
Poolbeg Pharma says Gilead in favour of its comb... 10-Jan-2025 ShareCast
Poolbeg Pharma granted new US patent 20-Nov-2024 ShareCast

Latest Poolbeg Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 2.72p
Change Today -0.029p
% Change -1.04 %
52 Week High 14.90
52 Week Low 2.70
Volume 435,665
Shares Issued 500.00m
Market Cap £13.61m
Beta 0.00

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
26.72% below the market average26.72% below the market average26.72% below the market average26.72% below the market average26.72% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Price Trend
90.33% below the market average90.33% below the market average90.33% below the market average90.33% below the market average90.33% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
13:34 11,718 @ 2.73p
13:17 443 @ 2.73p
11:27 2,000 @ 2.72p
10:50 300,000 @ 2.76p
10:35 50,000 @ 2.70p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page